5-Hydroxymethylcytosines in circulating cell-free DNA reveal a diagnostic biomarker for glioma
Gliomas typically have unfavorable prognosis, due to late detection and interventions. However, effective biomarkers for early glioma diagnosis based on 5-hydroxymethylcytosines (5 hm C) in circulating cell-free DNA (cfDNA) are not currently available. 5 hm C profiles in GSE132118 set were subjected...
Main Authors: | Chunyu Zhang, Wei Zhou, Yinqiu Tan, Daofeng Tian, Chunlong Zhong |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-10-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844022023106 |
Similar Items
-
5-Hydroxymethylcytosine modifications in circulating cell-free DNA: frontiers of cancer detection, monitoring, and prognostic evaluation
by: Danjun Song, et al.
Published: (2025-03-01) -
IDH1 mutation is detectable in plasma cell-free DNA and is associated with survival outcome in glioma patients
by: Stefania Crucitta, et al.
Published: (2024-01-01) -
Circulating cell-free DNA as a biomarker for diagnosis of Schistosomiasis japonica
by: Yu Zhang, et al.
Published: (2024-03-01) -
The diagnostic accuracy of circulating free DNA for the detection of KRAS mutation status in colorectal cancer: A meta‐analysis
by: Wenli Xie, et al.
Published: (2019-03-01) -
Role of cell-free DNA and extracellular vesicles for diagnosis and surveillance in patients with glioma
by: Busra Karacam, et al.
Published: (2024-06-01)